Trelegy Ellipta

Theravance gets a fresh start
Theravance gets a fresh start
EP Vantage
Theravance
GSK
Trelegy Ellipta
Royalty Pharma
Flag link:
FDA approves Trelegy Ellipta as once-daily single inhaler triple therapy for asthma and COPD
FDA approves Trelegy Ellipta as once-daily single inhaler triple therapy for asthma and COPD
Pharmaceutical Business Review
GSK
Innovia
Trelegy Ellipta
COPD
asthma
FDA
Flag link:
FDA's Advisory Committee to Review Claims That GlaxoSmithKline's Trelegy Ellipta Reduces Mortality
FDA's Advisory Committee to Review Claims That GlaxoSmithKline's Trelegy Ellipta Reduces Mortality
Motley Fool
GSK
FDA
advisory panels
COPD
Trelegy Ellipta
Flag link:
GlaxoSmithKline leans on respiratory franchise with Trelegy share-grab
GlaxoSmithKline leans on respiratory franchise with Trelegy share-grab
Fierce Pharma
GSK
Trelegy Ellipta
COPD
Flag link:
GSK, Innoviva file sNDA to seek US approval for Trelegy Ellipta in asthma
GSK, Innoviva file sNDA to seek US approval for Trelegy Ellipta in asthma
Pharmaceutical Business Review
GSK
Innoviva
Trelegy Ellipta
asthma
Flag link:
With latest data, can AstraZeneca's COPD triple combo rival Glaxo's Trelegy?
With latest data, can AstraZeneca's COPD triple combo rival Glaxo's Trelegy?
Fierce Pharma
AstraZeneca
GSK
COPD
Trelegy Ellipta
PT010
Flag link:
GSK's Trelegy Ellipta Gains New Indication in the US for the Treatment of Patients With COPD
GSK's Trelegy Ellipta Gains New Indication in the US for the Treatment of Patients With COPD
CP Wire
GSK
Trelegy Ellipta
COPD
Innovia
FDA
Flag link:
GSK's Trelegy Ellipta Gains New Indication in the US for the Treatment of Patients With COPD
GlaxoSmithKline
Trelegy Ellipta
COPD
Flag link:
GSK, Innoviva seek expanded label for triple inhaler
GSK, Innoviva seek expanded label for triple inhaler
Drug Delivery Business News
GSK
Innoviva
triple inhaler
Trelegy Ellipta
COPD
Flag link:
GSK, Innoviva seek to expand scope of Trelegy Ellipta
GSK, Innoviva seek to expand scope of Trelegy Ellipta
Pharma Times
GSK
Innoviva
Trelegy Ellipta
COPD
Flag link:
With Advair copies looming, GSK keeps focus on new drugs
With Advair copies looming, GSK keeps focus on new drugs
Biopharma Dive
GSK
earnings
Advair
Trelegy Ellipta
Shingrix
Flag link:
GlaxoSmithKline, needing a sales surge, wins FDA nod for $1B-plus prospect Trelegy
GlaxoSmithKline, needing a sales surge, wins FDA nod for $1B-plus prospect Trelegy
Fierce Pharma
GSK
FDA
Trelegy Ellipta
COPD
Flag link:
GSK’s triple-med COPD inhaler wins recommendation for approval in EU
GSK’s triple-med COPD inhaler wins recommendation for approval in EU
Drug Delivery Business News
GSK
COPD
Trelegy Ellipta
Europe
Flag link: